Clinical Trial Update: A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Lorecivivint (SM04690) evaluating safety and efficacy in moderately to severely symptomatic knee osteoarthritis (STRIDES) ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Lorecivivint (SM04690)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED